Abstract
OBJECTIVE:
To prospectively evaluate the primary causes for the use of mechanical ventilation in near-term neonates and to determine the rates of death, chronic lung disease, and neurological complications in these infants.
STUDY DESIGN:
We collected data on 1011 neonates who were ≥34 weeks' estimated gestational age; intubated within 72 hours of birth; and expected to require ventilation for more than 6 hours.
RESULTS:
The study population had a mean estimated gestational age of 37±2 weeks; had a mean birth weight of 2.9±0.6 kg; and were predominantly male (62%), white (69%), and delivered by cesarean section (55%). Respiratory distress syndrome (n=437) was the most common pulmonary illness. Chronic lung disease was diagnosed in 109 (11%); neurological complications were reported in 86 (9%); and 51 (5%) patients died.
CONCLUSIONS:
Neonates ≥34 weeks who require mechanical ventilation represent a high-risk population who have significant morbidity and mortality.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993–1994. Pediatrics 2000;105(6):1216–1226.
Horbar JD, Plsek PE, Leahy K . NIC/Q 2000: establishing habits for improvement in neonatal intensive care units. Pediatrics 2003;111(4 Part 2):e397–e410.
Lee SK, McMillan DD, Ohlsson A, et al. Variations in practice and outcomes in the Canadian NICU network: 1996–1997. Pediatrics 2000;106(5):1070–1079.
Buhrer C, Grimmer I, Metze B, Obladen M . The CRIB (Clinical Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very low birth weight infants. Intensive Care Med 2000;26(3):325–329.
Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA . Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992–1995. Arch Pediatr Adolesc Med 2000;154(7):725–731.
Wadhawan R, Vohr BR, Fanaroff AA, et al. Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery? Am J Obstet Gynecol 2003;189(2):501–506.
Bennett CC, Johnson A, Field DJ . A comparison of clinical variables that predict adverse outcome in term infants with severe respiratory failure randomised to a policy of extracorporeal membrane oxygenation or to conventional neonatal intensive care. J Perinat Med 2002;30(3):225–230.
Clark RH, Huckaby JL, Kueser TJ, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J Perinatol 2003;23(4):300–303.
Angus DC, Linde-Zwirble WT, Clermont G, Griffin MF, Clark RH . Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med 2001;164(7):1154–1160.
UK Collaborative ECMO Trail Group. The collaborative UK ECMO (extracorporeal membrane oxygenation) trial: follow-up to 1 year of age. Pediatrics 1998;101(4):E1.
Finer NN, Barrington KJ . Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2001; (4):CD000399.
Roy BJ, Rycus P, Conrad SA, Clark RH . The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry. Pediatrics 2000;106(6):1334–1338.
The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 2000;136(5):611–617.
Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH . Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 1998;132(1):40–47.
O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989;84(6):957–963.
The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. N Engl J Med 1997;336(9):597–604.
Clark RH, Yoder BA, Sell MS . Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994;124(3):447–454.
Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose–response, multicenter study. The I-NO/PPHN Study Group. Pediatrics 1998;101(3 Part 1):325–334.
Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001;344(2):95–101.
Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000;342(7):469–474.
Boedy RF, Howell CG, Kanto Jr WP . Hidden mortality rate associated with extracorporeal membrane oxygenation. J Pediatr 1990;117(3):462–464.
Konduri GG, Solimano A, Sokol GM, et al. A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics 2004;113(3 Part 1):559–564.
Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000;105(1 Part 1):14–20.
Acknowledgements
We would like to thank the following persons for administrative support in running this clinical trial: C. Benson, E. Dodd, D. Handler, A. Kelleher, P. Thomas, and J. Whittaker.
Author information
Authors and Affiliations
Consortia
Additional information
Manuscript prepared by Reese H. Clark, MD for the principal investigators.
Disclosures: This work was supported by Pediatrix Medical Group, Inc. and an unrestricted grant from INO Therapeutics, Inc.
Rights and permissions
About this article
Cite this article
Clark, R., The Near-Term Respiratory Failure Research Group. The Epidemiology of Respiratory Failure in Neonates Born at an Estimated Gestational Age of 34 Weeks or More. J Perinatol 25, 251–257 (2005). https://doi.org/10.1038/sj.jp.7211242
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211242
This article is cited by
-
Does closed-loop automated oxygen control reduce the duration of supplementary oxygen treatment and the amount of time spent in hyperoxia? A randomised controlled trial in ventilated infants born at or near term
Trials (2023)
-
Global, Regional and National Trends in the Burden of Neonatal Respiratory Failure and essentials of its diagnosis and management from 1992 to 2022: a scoping review
European Journal of Pediatrics (2023)
-
Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
BMC Pediatrics (2019)
-
Surfactant reduced the mortality of neonates with birth weight ⩾1500 g and hypoxemic respiratory failure: a survey from an emerging NICU network
Journal of Perinatology (2017)
-
Heterogeneity of respiratory distress syndrome: risk factors and morbidity associated with early and late gestation disease
BMC Pregnancy and Childbirth (2016)